Dedicated to driving psychedelic research,
education and innovation forward.
Hayim is an adventurous business leader driven by the double bottom line of doing well financially and doing good in the world. He is experienced in international business development and financing and has spent his 20+ year career building global healthcare companies. Recently, Hayim led iCAN’s Incubator, and took the helm at PsyTech in February 2020.
DIRECTOR OF FINANCE
In his 15 years’ experience as a CPA, Mark has owned his own business, providing tax, consulting and CFO services to select clients. He served as a founding shareholder and CFO for two pharmaceutical cannabis companies, both of which resulted in exits as sales to public companies. Being a business leader in the cannabis space, Mark is well positioned to support PsyTech.
Cory has an unparalleled track record of launching successful digital media properties and transforming iconic brands across all platforms for the past 20 years. He has led teams as a C-level executive for some of the biggest publishers in the world and most recently as a pioneer in the cannabis space at Civilized. Jones is at the forefront of developing powerhouse brands for new and emerging markets.
DIRECTOR OF OPERATIONS
Tali directed an autism consulting company for over 16 years and supported families by developing online community and educational platforms. More recently, she served as the operations manager for several divisions of iCAN. Compelled by the potential for psychedelics to bring health and healing to many, she is enthusiastically bringing her skills to the PsyTech team.
Deborah is a mother, actress and artist and has coached many in how best to present their most authentic self to others. Now director of events for PsyTech, she uses her creative flair to help make change through creating a platform for thought leaders to share their knowledge with the world.
DIRECTOR OF LIFE SCIENCES
Yaron is a product development specialist and has been involved in several "First-in-Human" clinical trials, taking multiple companies through FDA and European regulatory approval. Having served as the Director of Life Sciences at iCAN, Yaron has the experience and knowledge necessary to guide our clinical and regulatory efforts forward.
ADMINISTRATION AND INVESTOR RELATIONS
Jenny is a mother, yogini and has 14 years’ team and operations management experience and more recently serves in administrative and executive assistant roles in accounting and finance. Passionate about improving quality of life and optimistic about the role psychedelics can play, Jenny is thankful for the opportunity to support the PsyTech team.
medical advisory board
DR. ROBIN ELY
Dr. Ely is a loving and enthusiastic mom and grandma and has practiced innovative integrative medicine for 35+ years. She was part of the NIH original treatment development team for Gaucher Disease, paving the way to the current modern field of lysosomal storage diseases. She has been an investor, educator, and board member of forward- thinking companies such as iCAN and PsyTech.
DR. MARK BRAUNSTEIN
With 22 years of clinical experience, Dr. B is dedicated to educating and elevating humanity to a healthier and happier place. He is the medical director for multiple mental health clinics, including a groundbreaking psychedelic psychotherapy practice in Boulder, Colorado. Additionally, Dr. B trained with Dr. Phil Wolfson and provides ketamine assisted psychotherapy, with a specialty in addiction and groups.
BOARD OF DIRECTORS
Pharmacist, entrepreneur and global cannabis disrupter, Saul has been instrumental in building the cannabis ecosystem. As CEO of iCAN: Israel Cannabis for the last 5 years, he drove this ecosystem forward by creating CannaTech, an international platform for cannabis thought leaders around the globe.